NCCN Guidelines for Patients
Mycosis Fungoides, Version 1.2016
Genetic counseling | Treatment
Stage III treatment
lists options for second-line treatment
of stage III cancers. Combination treatment is one
option. It may consist of skin and systemic treatment.
Otherwise, it may consist of two systemic treatments.
Specific regimens of combination treatment are listed
in the chart. A second option for second-line treatment
is a clinical trial.
Start treatment again if the cancer was fully treated
but came back as stage III. People often have good
results with the same treatment. If a new treatment
will be received, the choice of which treatment will be
partly based on how much of your skin has lesions. If
one or two courses of first-line treatment didn’t work,
try another treatment listed in the chart.
You may have already tried multiple courses of
first-line treatment without much change. Despite
treatment, the cancer may be worse. In either case,
options are listed in Chart 4.4.3
lists options for third-line treatment
of stage III cancers. There are four options. You
may be able to join a clinical trial. The second
option is systemic treatment. The third option is
to take alemtuzumab. The fourth option listed is a
nonmyeloblative allogeneic stem cell transplant.